von Hippel-Lindau disease

[1] The inducible elongin A elongation activation domain: Structure, function and interaction with the elongin BC complex [J]. EMBO JOURNAL, 1996, 15 (20) : 5557 - 5566

[2] ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II [J]. SCIENCE, 1995, 269 (5229) : 1439 - 1443

[3] SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box [J]. CELL, 1996, 86 (02) : 263 - 274

[4] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220

[5] ISLET CELL TUMORS IN VONHIPPEL-LINDAU DISEASE - INCREASED PREVALENCE AND RELATIONSHIP TO THE MULTIPLE ENDOCRINE NEOPLASIAS [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (03) : 501 - 505

[6] VON HIPPEL-LINDAU (VHL) DISEASE WITH PHEOCHROMOCYTOMA IN THE BLACK-FOREST REGION OF GERMANY - EVIDENCE FOR A FOUNDER EFFECT [J]. HUMAN GENETICS, 1995, 95 (05) : 551 - 556

[7] CHEN F, 1995, CANCER RES, V55, P4804

[8] GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE - CORRELATIONS WITH PHENOTYPE [J]. HUMAN MUTATION, 1995, 5 (01) : 66 - 75

[9] Genotype-phenotype correlation in vonHippel-Lindau disease: Identification of a mutation associated with VHL type 2A [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (08) : 716 - 717

[10] Chen L B, 1978, Ann N Y Acad Sci, V312, P366, DOI 10.1111/j.1749-6632.1978.tb16814.x

[1] The inducible elongin A elongation activation domain: Structure, function and interaction with the elongin BC complex [J]. EMBO JOURNAL, 1996, 15 (20) : 5557 - 5566

[2] ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II [J]. SCIENCE, 1995, 269 (5229) : 1439 - 1443

[3] SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box [J]. CELL, 1996, 86 (02) : 263 - 274

[4] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220

[5] ISLET CELL TUMORS IN VONHIPPEL-LINDAU DISEASE - INCREASED PREVALENCE AND RELATIONSHIP TO THE MULTIPLE ENDOCRINE NEOPLASIAS [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (03) : 501 - 505

[6] VON HIPPEL-LINDAU (VHL) DISEASE WITH PHEOCHROMOCYTOMA IN THE BLACK-FOREST REGION OF GERMANY - EVIDENCE FOR A FOUNDER EFFECT [J]. HUMAN GENETICS, 1995, 95 (05) : 551 - 556

[7] CHEN F, 1995, CANCER RES, V55, P4804

[8] GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE - CORRELATIONS WITH PHENOTYPE [J]. HUMAN MUTATION, 1995, 5 (01) : 66 - 75

[9] Genotype-phenotype correlation in vonHippel-Lindau disease: Identification of a mutation associated with VHL type 2A [J]. JOURNAL OF MEDICAL GENETICS, 1996, 33 (08) : 716 - 717

[10] Chen L B, 1978, Ann N Y Acad Sci, V312, P366, DOI 10.1111/j.1749-6632.1978.tb16814.x